retatrutide dosing retatrutide clinical trial dose Dosage: What Evidence Currently Shows – Bolt Pharmacy Retatrutide Dosage: How Many Units

In these cases, therapy can be continued

These risks have not been established for retatrutide in humans and should be regarded as hypothetical at this stage, pending further trial data

Covers nausea rates from pooled STEP and SURMOUNT data, why patients discontinue, the lean mass question, gallbladder and pancreatitis risk, the thyroid boxed warning, and what happens after stopping

Starting low and escalating gradually over defined 4-week intervals produced the best combination of efficacy and tolerability

24 weeks 24 syringes 1 syringe per weekly injection

The trial demonstrated dose-dependent weight loss, with participants receiving 12 mg achieving a mean body weight reduction of approximately 24% over 48 weeks a result that has attracted considerable scientific and public interest